These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16216183)

  • 1. [Factors influencing incipient diabetic nephropathy: ESODIAH study].
    Biarnés J; Masana L; Morales C; Pintó X; Ricart W;
    Med Clin (Barc); 2005 Oct; 125(11):401-4. PubMed ID: 16216183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.
    Ravid M; Brosh D; Ravid-Safran D; Levy Z; Rachmani R
    Arch Intern Med; 1998 May; 158(9):998-1004. PubMed ID: 9588433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study.
    Gall MA; Hougaard P; Borch-Johnsen K; Parving HH
    BMJ; 1997 Mar; 314(7083):783-8. PubMed ID: 9080995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcapillary escape rate of albumin in type II diabetic patients. The relationship with microalbuminuria and hypertension.
    Nannipieri M; Penno G; Rizzo L; Pucci L; Bandinelli S; Mattei P; Taddei S; Salvetti A; Navalesi R
    Diabetes Care; 1997 Jun; 20(6):1019-26. PubMed ID: 9167118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypercholesterolemia and diabetic nephropathy: a multifactorial association].
    Salinas I; Romero R
    Med Clin (Barc); 2005 Oct; 125(11):415-6. PubMed ID: 16216187
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients.
    Wirta OR; Pasternack AI; Mustonen JT; Koivula TA; Harmoinen A
    Nephrol Dial Transplant; 1996 Mar; 11(3):449-56. PubMed ID: 8671814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of plasma von Willebrand factor and the risk of macro- and microvascular disease in type 2 diabetic patients with microalbuminuria.
    Gaede P; Vedel P; Parving HH; Pedersen O
    Nephrol Dial Transplant; 2001 Oct; 16(10):2028-33. PubMed ID: 11572892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of blood pressure level over a three years period in non-insulin dependent diabetic subjects according to their microalbuminuria].
    Mayaudon H; Bauduceau B; Ducorps M; Belmejdoub G; Poirier JM
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1045-9. PubMed ID: 8949376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria.
    Chiarelli F; Catino M; Tumini S; de Martino M; Mezzetti A; Verrotti A; Vanelli M
    Diabetes Care; 1999 Jul; 22(7):1158-64. PubMed ID: 10388982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lower levels of HDL2 cholesterol are associated with microalbuminuria in patients with type 1 diabetes].
    Bulum T; Duvnjak L; Prkacin I
    Acta Med Croatica; 2011; 65(3):243-50. PubMed ID: 22359892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.
    Parving HH; Lehnert H; Bröchner-Mortensen J; Gomis R; Andersen S; Arner P;
    N Engl J Med; 2001 Sep; 345(12):870-8. PubMed ID: 11565519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Microalbuminuria and diabetic nephropathy. Detection and correlation with other degenerative complications].
    Thivolet C; Ayzac L; Simonet C; Rebattu B; Bernard P; Tourniaire J
    Presse Med; 1990 Jun; 19(23):1075-80. PubMed ID: 2141408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study).
    Januszewicz A; Ritz E; Viberti G; Mimran A; Rabelink AJ; Rump LC; Ruilope LM; Katayama S; Ito S; Izzo JL; Haller H
    J Hum Hypertens; 2011 Nov; 25(11):679-85. PubMed ID: 21150933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes: a post-hoc analysis of The Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study.
    Makino H; Haneda M; Babazono T; Moriya T; Ito S; Iwamoto Y; Kawamori R; Takeuchi M; Katayama S;
    Hypertens Res; 2008 Apr; 31(4):657-64. PubMed ID: 18633177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albuminuria and associated medical risk factors: a cross-sectional study in 451 type II (noninsulin-dependent) diabetic patients. Part 2.
    Torffvit O; Agardh E; Agardh CD
    J Diabet Complications; 1991; 5(1):29-34. PubMed ID: 1830316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
    Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
    Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for development of microalbuminuria in diabetic and nondiabetic normoalbuminuric hypertensives with high or very high cardiovascular risk - a twelve-month follow-up study.
    Cotter J; Oliveira P; Cunha P; Polónia J
    Nephron Clin Pract; 2009; 113(1):c8-15. PubMed ID: 19590230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular hyperfiltration in microalbuminuric NIDDM patients.
    Vedel P; Obel J; Nielsen FS; Bang LE; Svendsen TL; Pedersen OB; Parving HH
    Diabetologia; 1996 Dec; 39(12):1584-9. PubMed ID: 8960846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetes.
    Hanai K; Babazono T; Nyumura I; Toya K; Tanaka N; Tanaka M; Ishii A; Iwamoto Y
    Nephrol Dial Transplant; 2009 Jun; 24(6):1884-8. PubMed ID: 19131352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.